Phenol

ApprovedSmall molecule

NNorthwestern University

Phenol is one of 63 small molecule programs targeting Pilonidal sinus. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Pilonidal SinusActive, not recruiting

Back PainActive, not recruiting

OsteoarthritisActive, not recruiting

Pilonidal SinusApproved

Active, not recruiting

Back PainPhase 1

Active, not recruiting

OsteoarthritisPreclinical

Active, not recruiting

Competition

Competitive Landscape

778 competitors in Osteoarthritis

#DrugCompanyPhaseTrials

Phenol

NNorthwestern University

Approved

2 2

Epidiolex

Jazz Pharmaceuticals

Preclinical

4 3

Ilaris

Novartis

Preclinical

2 4

Toradol

Roche

Preclinical

1 5

Voltaren

CCerimon Pharmaceuticals

Preclinical

4 6

Glucophage

Boehringer Ingelheim

Preclinical

1 7

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Preclinical

1 8

Protonix

WWyeth-Lederle Vaccines

Preclinical

1 9

Catapres

Boehringer Ingelheim

Preclinical

1 10

MS Contin

HHikma Pharmaceuticals LLC

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Osteoarthritis2 trials

Phenol Neurolysis Versus Local Anesthetic Plus Steroid Genicular Nerve Block in Knee Osteoarthritis

Active, not recruiting·SSalim Sencar··NCT07267039·42 enrolled

Ultrasound-guided Genicular Nerve Block With Phenol for the Treatment of Chronic Pain Due to Knee Osteoarthritis

Unknown status·FFederal University of São Paulo·N/A·NCT03601533·15 enrolled

Local Anesthetic1 trial

Comparison of the Efficacy of Phenol Block and Corticosteroid-Local Anesthetic Block Applied to the Genicular Nerve

Unknown status·GGaziler Physical Medicine and Rehabilitation Education and Research Hospital·N/A·NCT06265675·88 enrolled

Back pain1 trial

Efficiency Comparison Between Methylprednisolone and Phenol 8% Treatment Using a Trans Sacral Approach - on Lower Back Pain and Limbs

Unknown status·—·Phase 1·NCT01468415·60 enrolled

Chronic Knee Pain1 trial

Phenol Neurolysis of Genicular Nerves for Chronic Knee Pain

Withdrawn·NNorthwestern University·Phase 4·NCT03973177

Radiofrequency Ablation1 trial

Comparison of Ganglion Impar Radiofrequency Ablation and Phenol Neurolysis Techniques for Chronic Coccydynia Treatment

Not yet recruiting·MMarmara University·N/A·NCT07021365·30 enrolled

1 more indication

Pilonidal sinus1 trial

Phenol and Silver Nitrate Application in Pilonidal Sinus

Completed·UUmraniye Education and Research Hospital·Phase 4·NCT04560049·44 enrolled

Sources

References

[1]
ClinicalTrials.gov — 7 trial records for Phenol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Phenol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Phenol. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Northwestern University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: NNorthwestern University

Phenol

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Osteoarthritis2 trials

Local Anesthetic1 trial

Back pain1 trial

Chronic Knee Pain1 trial

Radiofrequency Ablation1 trial

Pilonidal sinus1 trial

References

Drug Info

Quick Facts

Related News